Skip to main content
SpringerLink
Log in

Auch bei Diabetes und Nierenerkrankungen

Noch mehr Rückenwind für kardioprotektive SGLT2-Hemmer

  • Medizin aktuell
  • AHA-Kongress 2020
  • Published:
CardioVasc Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Springer Medizin, Neu-Isenburg, Deutschland

    Peter Overbeck

Authors
  1. Peter Overbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Overbeck, P. Noch mehr Rückenwind für kardioprotektive SGLT2-Hemmer. CV 21, 8–9 (2021). https://doi.org/10.1007/s15027-020-3459-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-020-3459-z

Search

Navigation